Stop Losing Revenue to Chargeback Errors and Rebate Leakage
IMA360 automates your entire chargeback, rebate, and gross-to-net workflow, from claim intake to resolution. Trusted to process $400B+ in annual revenue and 600M+ transactions for pharmaceutical and biotech organizations.
Get a personalized demo
Tell us a bit about yourself and we'll reach out within one business day. No sales pressure.
Customer Rebate Dashboard
Manage customer rebate contracts with full lifecycle tracking and accrual visibility
Rebates by Type
Contracts by Status
Rebates by Region
Rebate Contracts
8 records| ID↑ | Contract↕ | Customer↕ | Type↕ | Value↕ | Accrued↕ | Paid↕ | Status↕ |
|---|---|---|---|---|---|---|---|
| RC-001 | Annual Volume Rebate – Acme Corp | Acme Corporation | Volume | $2,450,000 | $1,245,000 | $890,000 | Active |
| RC-002 | Growth Incentive – BetaChem | BetaChem Industries | Growth | $1,890,000 | $945,000 | $670,000 | Active |
| RC-003 | Q1 Promotional Rebate – Gamma | Gamma Distribution | Mix | $780,000 | $780,000 | $780,000 | Expired |
| RC-004 | Loyalty Program – Delta Pharma | Delta Pharmaceuticals | Loyalty | $3,200,000 | $2,890,000 | $2,100,000 | Active |
| RC-005 | Volume Commitment – Epsilon | Epsilon Materials | Volume | $1,650,000 | $0 | $0 | Pending |
| RC-006 | Channel Partner – Zeta Group | Zeta Distribution Group | Growth | $4,100,000 | $2,050,000 | $1,560,000 | Active |
| RC-010 | Enterprise Agreement – Lambda | Lambda Manufacturing | Volume | $5,800,000 | $2,900,000 | $2,175,000 | Active |
| RC-012 | Strategic Growth – Nu Health | Nu Healthcare | Growth | $2,780,000 | $0 | $0 | Pending |














Your commercial systems can’t keep up
Pharmaceutical and biotech companies manage an extraordinary web of pricing, rebates, chargebacks, fees, and discounts, each varying by contract, channel, payer, and geography. The average pharma manufacturer loses 2–5% of revenue to chargeback discrepancies alone. As portfolios expand and access models evolve, spreadsheets and fragmented systems create blind spots that cost you real money.
- Revenue Bleeding from Chargeback Errors. Wholesalers, GPOs, and PBMs submit thousands of chargeback claims monthly. Manual validation leads to overpayments, disputes, and write-offs. Errors compound across thousands of claims and erode your margins.
- Gross-to-Net Numbers You Can’t Trust. With Medicaid, 340B, commercial rebates, and distribution fees, your gap between gross and net revenue grows wider and harder to forecast when it lives in disconnected spreadsheets.
- Contract Deviations Go Undetected. Managing hundreds of contracts across government programs, GPOs, and commercial payers with different terms, tiers, and eligibility rules creates constant compliance exposure. Deviations go undetected until audit, and by then the damage is done.
- Pricing Changes Create Downstream Errors. WAC, ASP, AMP, and Best Price calculations require precise, auditable data flows. Manual processes introduce errors that cascade across wholesalers, distributors, and payers, triggering regulatory penalties.
One Platform for Every Dollar Between Gross and Net
IMA360 replaces spreadsheet-driven processes with automated workflows and validation, centralizing your contracts, chargebacks, rebates, and pricing into a single system where finance, commercial, and compliance teams share an auditable view of every revenue adjustment.
- Full EDI Chargeback Automation. Automate your entire chargeback workflow — EDI 844/845/849 receipt through validation, reconciliation, and settlement — with zero manual intervention. No middleware required.
- Rebate Program Management. Manage rebate programs across GPO contracts, specialty pharmacy, and direct accounts with automated accrual calculations and payment tracking.
- Gross-to-Net Transparency. Real-time visibility into every deduction between WAC and pocket price, including Medicaid, 340B, commercial rebates, distribution fees, and chargebacks.
- GPO and 340B Compliance. Automated eligibility verification, roster management, and contract compliance across government and commercial programs.
- ERP-Agnostic Architecture. Works alongside SAP®, Oracle®, or any ERP without vendor lock-in. Pre-configured connectors reduce implementation time by 60%.
- User-Configurable Programs. Launch new rebate, chargeback, and incentive programs without custom development. Your team configures programs directly, reducing time to market from months to weeks.
From Transaction Data to Settled Rebates
IMA360 ingests your transaction and contract data, calculates rebates and chargebacks using your business rules, and pushes results back to your ERP as debit and credit memos.
Data In
Process & Calculate
Results Out
Data In
ERP System
Transaction Data · SAP, Oracle, NetSuite
Agreements
Contracts & Rules · GPO, Customer, Supplier
Master Data
Products & Prices · EDI, Rosters, Catalogs
Results Out
Accruals & CO-PA
Profitability analysis · Real-time sync to GL
Debit & Credit Memos
Posted to ERP · Real-time or batch
Reports & Audit Trails
GTN visibility · SOX, IFRS compliance
Supplier Portal
Claims, statements, disputes
Customer Portal
Contracts, reporting, tier achievement
What our customers say
5.0 / 5.0from 11 verified reviewers on Gartner Peer Insights“IMA Platform centralizes rebate management and improves incentive program transparency.”
“Complete revenue management application that manages our business efficiently.”
“Real-time deal profitability enhances profit margin visibility and commission tracking.”
Frequently Asked Questions
How does IMA360 handle gross-to-net calculations?
IMA360 gives you full transparency into every GTN adjustment, including rebates, chargebacks, admin fees, returns, and discounts, with real-time calculations and forecasting. The platform validates adjustments against contract terms automatically and provides drill-down visibility from portfolio-level totals to individual line items. Your finance team gets GTN numbers they can trust, not spreadsheets they have to reconcile.
Can IMA360 manage our distributor chargeback process?
Yes. IMA360 automates your entire chargeback lifecycle, from EDI 844 claim submission through EDI 849 reconciliation and dispute management. The platform matches claims against contract terms, flags discrepancies automatically, and provides complete audit trails for every transaction across your wholesaler network.
How does IMA360 handle 340B chargebacks?
IMA360 validates 340B contract pricing automatically, prevents duplicate discounts across covered entities and contract pharmacies, and maintains audit-ready records for every 340B transaction. The platform flags pricing discrepancies, tracks covered entity eligibility, and generates the reporting your team needs for HRSA compliance.
Can IMA360 integrate with my existing ERP (SAP, Oracle)?
IMA360 connects natively with SAP, Oracle, and other major ERP platforms through pre-built connectors. The integration is bidirectional, pulling product, customer, and contract data in while pushing governed pricing and incentive data out. The platform processes EDI 810, 844, and 849 transactions automatically, connecting your commercial processes end to end without custom code.
How long does implementation take for pharmaceutical companies?
Most IMA360 implementations for pharmaceutical organizations go live within 6 to 18 months. That includes data migration, ERP integration, user training, and production deployment. Your team can configure new rebate and chargeback programs directly, with no waiting for a services engagement to stand up each new program.
What’s the difference between distributor and manufacturer chargebacks?
Distributor chargebacks are claims submitted by wholesalers to recover the difference between WAC and the contracted price they sold at. Manufacturer chargebacks flow in the opposite direction as claims against manufacturers for pricing adjustments. IMA360 automates both sides of the chargeback process with automated validation, matching, and reconciliation.
Can IMA360 manage GPO contracts and admin fees?
Yes. IMA360 automates GPO membership roster management, pricing tier calculations, and administrative fee processing. The platform validates pricing against GPO contract terms in real time, tracks tier commitments, and calculates admin fees automatically, eliminating the spreadsheets most pharma companies use to manage these programs.
Is IMA360 compliant with pharmaceutical industry regulations?
IMA360 is SOC 2 compliant with enterprise-grade security, role-based access controls, and complete audit trails for every pricing decision, contract change, and incentive execution. Every action in the system is traceable, timestamped, and tied to a specific user, giving your compliance team the documentation they need for internal audits and regulatory reviews.
What systems does IMA360 replace?
IMA360 replaces a wide range of legacy and point solutions for pricing, rebate, chargeback, and incentive management. Organizations commonly migrate to IMA360 from SAP Vistex®, SAP Condition Contract Management, Model N®, Vendavo®, PROS®, Zilliant®, Pricefx®, and custom-built or spreadsheet-based solutions. Because IMA360 is ERP-agnostic and API-first, it works alongside any ERP system and replaces tools that lack modern integration, automation, or cross-functional visibility.
Ready to Stop Losing Revenue?
See how IMA360 automates your chargeback, rebate, and GTN workflows and gives your team real-time visibility across every commercial process.
Trademark Attribution. SAP®, SAP S/4HANA®, and SAP Condition Contract Management are trademarks or registered trademarks of SAP SE in Germany and other countries. Vistex® is a registered trademark of Vistex, Inc. Oracle® is a registered trademark of Oracle Corporation. Model N® is a trademark of Model N, Inc. Vendavo®, Pricefx®, PROS®, Zilliant®, Flintfox®, and Enable® are trademarks of their respective owners. IMA360 is not affiliated with, endorsed by, sponsored by, or partnered with any of these companies. All product names, logos, and brands are property of their respective owners and are used here for identification purposes only under the doctrine of nominative fair use. Information about competitor products is based on publicly available sources and may not reflect the most current product offerings.